Rhythm Pharmaceuticals
RYTM
RYTM
115 hedge funds and large institutions have $1.81B invested in Rhythm Pharmaceuticals in 2022 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 42 increasing their positions, 28 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
14% more funds holding
Funds holding: 101 → 115 (+14)
1.01% more ownership
Funds ownership: 109.57% → 110.59% (+1%)
17% less funds holding in top 10
Funds holding in top 10: 6 → 5 (-1)
Holders
115
Holding in Top 10
5
Calls
$15.5M
Puts
$12.9M
Top Buyers
| 1 | +$15.6M | |
| 2 | +$15.5M | |
| 3 | +$14M | |
| 4 |
Goldman Sachs
New York
|
+$12.4M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$10.5M |
Top Sellers
| 1 | -$54.8M | |
| 2 | -$17.4M | |
| 3 | -$4.69M | |
| 4 |
Primecap Management
Pasadena,
California
|
-$3.37M |
| 5 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
-$2.77M |